TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 77 filers reported holding TREACE MED CONCEPTS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42 | +740.0% | 3,225 | +1701.7% | 0.00% | – |
| Q2 2023 | $5 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q1 2023 | $5 | +25.0% | 179 | 0.0% | 0.00% | – |
| Q4 2022 | $4 | -99.9% | 179 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | -85.7% | 179 | -90.7% | 0.00% | – |
| Q2 2022 | $28,000 | +833.3% | 1,929 | +977.7% | 0.00% | – |
| Q4 2021 | $3,000 | -50.0% | 179 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | – | 179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 1,907,823 | $25,011,560 | 2.31% |
| FORMULA GROWTH LTD | 222,269 | $2,913,947 | 0.99% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,193,939 | $15,652,540 | 0.94% |
| EMERALD ADVISERS, LLC | 1,473,281 | $19,314,713 | 0.94% |
| Perceptive Advisors | 1,834,060 | $24,044,527 | 0.80% |
| NEXT CENTURY GROWTH INVESTORS LLC | 512,738 | $6,721,995 | 0.73% |
| OBERWEIS ASSET MANAGEMENT INC/ | 355,600 | $4,661,916 | 0.50% |
| Novo Holdings A/S | 360,000 | $4,719,600 | 0.35% |
| TimesSquare Capital Management, LLC | 1,433,429 | $18,792 | 0.29% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 677,733 | $8,885,080 | 0.18% |